NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
1.730
+0.030 (1.76%)
At close: Mar 9, 2026, 4:00 PM EDT
1.740
+0.010 (0.58%)
After-hours: Mar 9, 2026, 7:46 PM EDT
NRx Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 55 | 27 | 38 | 75 | 281 | 66 | |
| Market Cap Growth | 86.28% | -30.71% | -48.99% | -73.29% | 328.57% | 1.96% | |
| Enterprise Value | 58 | 31 | 39 | 57 | 243 | - | |
| Last Close Price | 1.70 | 2.20 | 4.60 | 11.10 | 47.80 | 244.00 | |
| PB Ratio | - | -1.14 | -3.26 | 10.13 | 13.51 | -1.50 | |
| P/TBV Ratio | - | - | - | 10.13 | 13.51 | - | |
| Debt / Equity Ratio | -0.40 | -0.27 | -0.78 | 1.42 | 0.03 | -0.02 | |
| Net Debt / Equity Ratio | -0.12 | -0.21 | -0.39 | -1.29 | -1.30 | 0.02 | |
| Net Debt / EBITDA Ratio | -0.20 | -0.24 | -0.17 | 0.22 | 0.29 | 0.09 | |
| Net Debt / FCF Ratio | -0.25 | -0.45 | -0.21 | 0.24 | 0.72 | 0.47 | |
| Quick Ratio | 0.26 | 0.07 | 0.24 | 1.29 | 2.32 | 0.06 | |
| Current Ratio | 0.29 | 0.15 | 0.36 | 1.66 | 2.74 | 0.06 | |
| Return on Equity (ROE) | - | - | - | -281.79% | - | - | |
| Return on Assets (ROA) | -97.83% | -224.60% | -104.08% | -94.66% | -330.91% | -378.83% | |
| Return on Capital Employed (ROCE) | 59.50% | 108.20% | 235.10% | -433.30% | -453.90% | 27.50% | |
| Earnings Yield | -69.83% | -94.69% | -78.73% | -52.95% | -33.11% | -78.94% | |
| FCF Yield | -22.93% | -40.09% | -56.56% | -52.96% | -13.41% | -3.46% | |
| Buyback Yield / Dilution | -79.43% | -40.50% | -15.20% | -40.17% | -36.90% | -220.58% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.